A Randomized Phase II Study of Low-Dose Decitabine Versus Azacitidine in Patients with Low- or Intermediate-1-Risk Myelodysplastic Syndromes: A Report on Behalf of the MDS Clinical Research Consortium
Year: 2016
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Blood
Authors: Elias J. Jabbour, Nicholas J. Short, Xuelin Huang, Abhishek Maiti, Tapan M. Kadia, Naval Daver, Gautam Borthakur, Courtney D DiNardo, Naveen Pemmaraju, Koji Sasaki, Zeev Estrov, Srdan Verstovsek, Farhad Ravandi, Yesid Alvarado, Mikkael A. Sekeres, Rami S. Komrokji, David P. Steensma, Amy E. DeZern, Gail J. Roboz, Darla Miller, Xiao Dong, Hagop M. Kantarjian, Guillermo Garcia-Manero
Institutions: The University of Texas MD Anderson Cancer Center, Cleveland Clinic, Moffitt Cancer Center, Dana-Farber Cancer Institute, Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2586555276